Twitxy Saved

Dr. Andrew Hendifar

@DrHendifar

I am a physician and scientist working to develop new medications for gastrointestinal malignancies -- particularly pancreatic cancer and neuroendocrine tumors.
Los Angeles cedars-sinai.edu/Bios---Physici… Joined May 2013
496 Following 907 Followers 617 Posts

Latest posts 5

Dr. Andrew Hendifar @DrHendifar
Nivolumab plus Ipilimumab in Microsatellite-Instability–High Metastatic Colorectal Cancer | New England Journal of Medicine nejm.org/doi/full/10.10….

Dual checkpoint inhibition with unprecedented outcomes in MSI-High colorectal cancer. A new standard of care.
www.nejm.org Nivolumab plus Ipilimumab in Microsatellite-Instability–High Metastatic Colorectal Cancer | NEJM Patients with microsatellite-instability–high (MSI-H) or mismatch-repair–deficient (dMMR) metastatic colorectal cancer have poor outcomes with standard chemotherapy with or without targeted therapi...
1 replies 4 reposts 13 likes 1.4K views View on X
Dr. Andrew Hendifar @DrHendifar
Understanding and Treating Pancreatic Cancer Cachexia | Blog | AACR - goo.gl/alerts/gCyikP #GoogleAlerts. Addressing cancer associated weight loss will become a pillar of cancer care in the near future. #PancreaticCancer @CSCancerCenter
www.aacr.org Understanding and Treating Pancreatic Cancer Cachexia  New advances in our understanding of cancer cachexia may provide hope for patients with pancreatic cancer.